Steven D. Harr's most recent trade in Sana Biotechnology Inc was a trade of 50,000 Restricted Stock Units done . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 50,000 | 100,000 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 50,000 | 7,968,596 | - | 0 | Common Stock | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 41,666 | 125,001 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2026 | 41,666 | 7,918,596 | - | 0 | Common Stock | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.10 per share. | 06 Mar 2026 | 12,819 | 7,944,251 | - | 3.1 | 39,739 | Common Stock |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Mar 2026 | 11,526 | 7,957,070 | - | 3.1 | 36,076 | Common Stock |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 166,667 | 166,667 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 150,000 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 7,889,750 | - | 0 | Common Stock | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 06 Mar 2025 | 12,820 | 7,876,930 | - | 2.6 | 32,819 | Common Stock |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 650,000 | 650,000 | - | - | Stock Options (Right to Buy) | |
| Sana biotech Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 760,000 | 760,000 | - | - | Stock Options (Right to Buy) |